StockWatch
·
Pharmaceuticals
Quarterly Result4 Nov 2026, 06:33 pm

Transchem Ltd Declares Q2 FY27 Unaudited Financial Results

AI Summary

Transchem Limited announced its Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, which were reviewed by the Audit Committee and the Statutory Auditors, Mathur & Co. The company reported total income of ₹396.28 Lakhs for the quarter ended September 30, 2026, with a profit before tax of ₹282.40 Lakhs. For the half-year ended September 30, 2026, total income was ₹907.64 Lakhs and profit before tax was ₹717.61 Lakhs. The company also disclosed the utilization of proceeds from a preferential issue of warrants for the acquisition of 100% equity share capital of Greshma Shares & Stocks Limited. The trading window for securities remains closed until 48 hours after the declaration of these results.

Key Highlights

  • Board approved Q2 FY27 unaudited financial results.
  • Total income for Q2 FY27 was ₹396.28 Lakhs.
  • Profit before tax for Q2 FY27 stood at ₹282.40 Lakhs.
  • Proceeds from warrants used for subsidiary acquisition.
  • Trading window closed until 48 hours post-results.